Press Release

HAPPE Spine and cultivate(MD)

cultivate(MD) Capital Funds Announces HAPPE Spine’s Additional Patents for Hydroxyapatite Porous Polyetheretherketone Devices

Press Release /

Grand Rapids, Mich., October 5th, 2022— cultivate(MD) Capital Funds LP, funds that are focused on investments into early-stage healthcare companies with innovative technologies, announces today that one of their portfolio companies, Grand Rapids, MI based HAPPE Spine was granted two more issued patents in a growing portfolio establishing HAPPE as the leader of next generation […]

cultivate(MD) Capital Funds Announces HAPPE Spine’s Additional Patents for Hydroxyapatite Porous Polyetheretherketone Devices Read More »

SpinTechMRI and Cultivate news and press release

culivate(MD) Capital Funds Announces Lead Participation in Portfolio Company SpinTech MRI’s Series A Financing

Press Release /

Grand Rapids, MI, July 25th, 2022 — Genesis Innovation Group’s cultivate(MD) Capital Funds LP, funds that are focused on investments into early-stage healthcare companies with innovative technologies, announced today that one of their portfolio companies, Bingham Farms, MI based SpinTech MRI announced a $6.5 million Series A financing.

culivate(MD) Capital Funds Announces Lead Participation in Portfolio Company SpinTech MRI’s Series A Financing Read More »

embody cultivate(MD) news

culivate(MD) Capital Funds Announces Portfolio Company Embody, Inc.’s FDA 510(k) Clearance for TAPESTRY® RC Rotator Cuff Repair System

Press Release /

Grand Rapids, MI, June 06, 2022 — Genesis Innovation Group’s cultivate(MD) Capital Funds LP, funds that are focused on investments into early-stage healthcare companies with innovative technologies, announced today that one of their portfolio companies, Norfolk, VA based Embody, Inc. has received FDA 510(k) clearance for theirTAPESTRY® RC System for Rotator Cuff Repair.  

culivate(MD) Capital Funds Announces Portfolio Company Embody, Inc.’s FDA 510(k) Clearance for TAPESTRY® RC Rotator Cuff Repair System Read More »

Virtual Incision robotic surgery ide

Virtual Incision Announces Approval to Complete Clinical Study Enrollment for its MIRA® Platform

Press Release /

FDA decision supported by an interim clinical study report on patient safety Lincoln, Neb. – April 19, 2022 – Virtual Incision Corporation, a medical device company pioneering the world’s first miniaturized robotic-assisted surgery (RAS) platform, today announced the U.S. Food and Drug Administration (FDA) has approved an Investigational Device Exemption (IDE) supplement to complete the

Virtual Incision Announces Approval to Complete Clinical Study Enrollment for its MIRA® Platform Read More »

Shoulder Innovations

Shoulder Innovations Announces FDA Clearance of New InSet™ Stemless Humeral Implant

Press Release /

GRAND RAPIDS, Mich., March 14, 2022—Shoulder Innovations Inc., (SI), a leading innovator in the development of shoulder replacement systems, announces the FDA Clearance of their latest component of the InSetTM Total Shoulder System, the InSetTM Stemless Humeral System. The InSetTM Stemless implant is the latest addition to the innovative and integrated InSetTM system, which already includes the successful InSet™ Glenoid, Humeral Short Stem and

Shoulder Innovations Announces FDA Clearance of New InSet™ Stemless Humeral Implant Read More »

Start typing and press enter to search